MENLO PARK, Calif., March 21 /PRNewswire/ -- SRI International, an independent nonprofit research and development organization, will present preliminary results of a diagnostic to detect neglected tropical diseases (NTDs) at the 239th National Meeting & Exhibition of the American Chemical Society (ACS) being held on March 21-25 in San Francisco.
At the ACS meeting, SRI researchers will disclose preliminary results involving the use of a small molecule sensor dye that can detect a metabolite specific to the parasites that cause three NTDs: Chagas, Leishmaniasis, and African Sleeping Sickness. This detectable metabolite is critical for the parasites' survival and is not found in humans.
To meet with SRI Biosciences at ACS 2010, visit booth #1412.
About SRI International
Silicon Valley-based SRI International is one of the world's leading independent research and technology development organizations. SRI, which was founded by Stanford University as Stanford Research Institute in 1946 and became independent in 1970, has been meeting the strategic needs of clients and partners for more than 60 years. Perhaps best known for its invention of the computer mouse and interactive computing, SRI has also been responsible for major advances in networking and communications, robotics, drug discovery and development, advanced materials, atmospheric research, education research, economic development, national security, and more. The nonprofit institute performs sponsored research and development for government agencies, businesses, and foundations. SRI also licenses its technologies, forms strategic alliances, and creates spin-off companies. In 2009, SRI's consolidated revenues, including its wholly owned for-profit subsidiary, Sarnoff Corporation, were approximately $470 million.
SRI International
